Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3747534

COc1ccc(S(=O)(=O)N2CC(C(=O)N3CCN4CCCC4C3)c3ccccc32)c2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 15/20 0.63
KCNH2 Q12809 1/20 0.62
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
AVPR1B P47901 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3750566 0.85 HTR6 (0.78) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3759673 0.84 HTR6 (0.88) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3754757 0.82 HTR6 (0.89) HTR6KCNH2ALDH1A1TSHRKDM4E
Trifluoroacetic Acid SCHEMBL3756951 0.81 HTR6 (0.64) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3752563 0.81 HTR6 (0.90) HTR6KCNH2KDM4ESMN1; SMN2
SCHEMBL3761881 0.80 HTR6 (0.81) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3749727 0.80 HTR6 (0.63) HTR6KCNH2ALDH1A1TSHRKDM4E
SCHEMBL3754246 0.79 HTR6 (0.77) HTR6KCNH2ALDH1A1AVPR1B
SCHEMBL3742336 0.78 HTR6 (1.00) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2
SCHEMBL3744515 0.77 HTR6 (0.74) HTR6KCNH2ALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838518-B2 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders N.V. ORGANON (NL) 2010-11-23 US disclosed
EP-1476151-B1 1-ARYLSULFONYL-3-SUBSTITUED INDOLE AND INDOLINE DERIVATES USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ORGANON NV (NL) 2008-07-16 EP disclosed